Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inPolitics Pakistan announces intention for second Nobel Peace Prize nomination for Trump over Gaza ceasefire role Pakistani Prime Minister Shehbaz Sharif on Monday announced that he intends to nominate President Donald… October 14, 2025
Posted inPolitics Mamdani breaks silence on freed Israeli hostages in statement that doesn’t mention Trump After facing backlash for staying silent as Israeli hostages were freed from Gaza, New York… October 14, 2025
Posted inPolitics Don’t fall for fake settlement sites that steal your data Sometimes, data breaches result in more than just free credit monitoring. Recently, Facebook began paying… October 14, 2025
Posted inPolitics Biden, Blinken take credit for groundwork behind Trump’s Gaza ceasefire deal Former President Joe Biden and former Secretary of State Antony Blinken both claimed some credit… October 14, 2025
Posted inPolitics Trump declines to commit to two-state solution after historic Gaza peace deal: ‘We’ll have to see’ President Donald Trump, when asked about the prospect of a two-state solution for Israel and… October 14, 2025
Posted inPolitics Kamala Harris commends ‘the President’ in Middle East statement, but omits Trump’s name Former Vice President Kamala Harris commended President Donald Trump and his team for helping to… October 14, 2025
Posted inPolitics Shutdown threatens rural hospitals, veterans’ care as Democrats block GOP plan, Emmer warns The No. 3 House Republican is accusing Democrats of making a hypocritical argument in their… October 14, 2025
Posted inPolitics EXCLUSIVE: New GOP report accuses Democrats of trying to ‘undermine’ healthcare in government shutdown fight The House GOP is releasing a report accusing Democrats of trying to undermine U.S. healthcare… October 14, 2025
Posted inStock US stocks bounce back sharply on Monday: S&P up 1.3%, Dow climbs 500 pts US stocks surged on Monday, reversing Friday’s steep sell-off, after President Donald Trump reassured markets… October 13, 2025
Posted inStock Estee Lauder surge 7% after Goldman Sachs upgrade to “Buy” Shares of Estée Lauder (NYSE: EL) rose sharply on Monday after Goldman Sachs upgraded the… October 13, 2025